Why the study?
Does pulmonary vasodilator therapy improve clinical outcomes in pregnant women with pulmonary hypertension?
Population
4 pregnant women with pulmonary hypertension
Design
Case_series
Authors
Loading...
May support vasodilator trial in select pregnant PH patients; hypothesis-generating and should not yet change practice.
Does pulmonary vasodilator therapy improve clinical outcomes in pregnant women with pulmonary hypertension?
Pulmonary vasodilator therapy with nifedipine and prostacyclin can benefit pregnant women with pulmonary hypertension, and a favorable response before conception may predict a successful pregnancy.
Easterling et al. (1999) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: